You are viewing an incomplete version of our website. Please click to reload the website as full version.

FAH antibody (Fumarylacetoacetate Hydrolase (Fumarylacetoacetase)) (AA 14-41)

Details for Product anti-FAH Antibody No. ABIN952405, Supplier: Log in to see
Antigen
  • CG14993
  • dfaa
  • Dmel\\CG14993
  • FAA
  • fb59b12
  • l(3)64Al
  • l(3)SH11
  • PSPTO3550
  • wu:fb59b12
  • zgc:55316
Epitope
AA 14-41, N-Term
19
15
6
4
3
2
2
2
1
1
Reactivity
Human
73
15
14
2
1
1
1
1
Host
Rabbit
62
11
Clonality
Polyclonal
Conjugate
This FAH antibody is un-conjugated
5
4
2
2
2
2
Application
Enzyme Immunoassay (EIA), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
62
40
33
12
9
7
2
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen KLH conjugated synthetic peptide between 14-41 amino acids from the N-terminal region of human FAH
Isotype Ig
Specificity This antibody recognizes Human Fumarylacetoacetase (N-term).
Purification Affinity Chromatography on Protein A
Alternative Name Fumarylacetoacetase (FAH Antibody Abstract)
Background This gene encodes the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia (HT).Synonyms: Beta-diketonase, FAA, FAH, Fumarylacetoacetate hydrolase
Molecular Weight 46374 Da
Gene ID 2184
NCBI Accession NP_000128
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Format Liquid
Concentration 0.25 mg/mL
Buffer PBS containing 0.09 % (W/V) Sodium Azide as preservative
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Supplier Images
Immunofluorescence (IF) image for anti-FAH antibody (Fumarylacetoacetate Hydrolase (Fumarylacetoacetase)) (AA 14-41) (ABIN952405) Confocal immunofluorescent analysis of Fumarylacetoacetase Antibody (N-term) Cat.-No ...
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) image for anti-FAH antibody (Fumarylacetoacetate Hydrolase (Fumarylacetoacetase)) (AA 14-41) (ABIN952405) Formalin fixed and paraffin embedded human liver tissue reacted with Fumarylacetoacet...
Western Blotting (WB) image for anti-FAH antibody (Fumarylacetoacetate Hydrolase (Fumarylacetoacetase)) (AA 14-41) (ABIN952405) Western blot analysis of Fumarylacetoacetase Antibody (N-term) in HepG2 cell line lys...
Background publications Joslyn, Ravindranathan, Brush, Schuckit, White: "Human variation in alcohol response is influenced by variation in neuronal signaling genes." in: Alcoholism, clinical and experimental research, Vol. 34, Issue 5, pp. 800-12, 2010 (PubMed).

Ferreira, ODonovan, Meng, Jones, Ruderfer, Jones, Fan, Kirov, Perlis, Green, Smoller, Grozeva, Stone, Nikolov, Chambert, Hamshere, Nimgaonkar, Moskvina, Thase, Caesar, Sachs, Franklin et al.: "Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder...." in: Nature genetics, Vol. 40, Issue 9, pp. 1056-8, 2009 (PubMed).

Liu, Pearlson, Windemuth, Ruano, Perrone-Bizzozero, Calhoun: "Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA." in: Human brain mapping, Vol. 30, Issue 1, pp. 241-55, 2008 (PubMed).

Bliksrud, Brodtkorb, Andresen, van den Berg, Kvittingen: "Tyrosinaemia type I--de novo mutation in liver tissue suppressing an inborn splicing defect." in: Journal of molecular medicine (Berlin, Germany), Vol. 83, Issue 5, pp. 406-10, 2005 (PubMed).